Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.43 EUR | +6.10% | -4.37% | +149.11% |
13/05 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
08/05 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |